Related Experiment Video
Updated: Aug 20, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein
Jun Matsumoto1, Takayuki Ohshima, Osamu Isono
1Laboratory of Human Tumor Viruses, Department of Viral Oncology, Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan.
Abstract:
Disruption of transcriptional control of cellular genes by human T-cell leukemia virus type-1 (HTLV-1) is thought to be associated, at least in part, with the development of adult T-cell leukemia. It has been reported that activating protein-1 (AP-1) is dysregulated by HTLV-1 infection. HTLV-1-encoded Tax elevates AP-1 activity through the induction of AP-1 family member gene expression, including c-Jun, JunD, c-Fos, and Fra-1. However, the precise mechanism by which HTLV-1 regulates AP-1 activity remains to be addressed. Recently, a novel viral protein named HTLV-1 basic leucine-zipper factor, HBZ, has been shown to interact with c-Jun and repress c-Jun-mediated transcription by abrogating its DNA-binding activity. In the course of investigating HBZ function, we found that HBZ reduced the steady-state levels of c-Jun, and the levels were restored by treatment with a proteasome inhibitor. Together, this indicates that HBZ promotes c-Jun degradation through a proteasome-dependent pathway. Furthermore, HBZ deletion mutants revealed that both the N-terminal and leucine-zipper region of HBZ were required for the elimination of c-Jun. These results suggest dual effects of HBZ on the suppression of AP-1 activity by inhibiting c-Jun function, which may contribute to the dysregulation of cell proliferation.
Insights
Human T-cell leukemia virus type-1 (HTLV-1) infection disrupts cellular gene transcription. The viral protein HBZ promotes degradation of c-Jun, a key component of activating protein-1 (AP-1), potentially contributing to adult T-cell leukemia development.
Area of Science:
- Virology
- Molecular Biology
- Oncology
Background:
- Human T-cell leukemia virus type-1 (HTLV-1) is linked to adult T-cell leukemia (ATL).
- HTLV-1 infection dysregulates activating protein-1 (AP-1) transcription factor activity.
- The viral protein Tax elevates AP-1 activity, while the role of HBZ is less understood.
Purpose of the Study:
- To elucidate the precise mechanism by which HTLV-1 regulates AP-1 activity.
- To investigate the function of the novel viral protein HBZ in relation to AP-1.
- To understand HBZ's role in the pathogenesis of HTLV-1-associated diseases.
Main Methods:
- Investigated the interaction between HBZ and c-Jun.
- Assessed the effect of HBZ on c-Jun protein levels.
- Utilized proteasome inhibitors to determine the degradation pathway of c-Jun.
- Employed HBZ deletion mutants to identify functional domains involved in c-Jun regulation.
Main Results:
- HBZ interacts with c-Jun and reduces its steady-state levels.
- c-Jun degradation induced by HBZ is dependent on the proteasome pathway.
- Both the N-terminal and leucine-zipper regions of HBZ are crucial for c-Jun elimination.
- HBZ exhibits dual effects: inhibiting c-Jun DNA-binding and promoting its degradation.
Conclusions:
- HBZ actively suppresses AP-1 activity through proteasomal degradation of c-Jun.
- This dual mechanism of HBZ action may contribute to the dysregulation of cell proliferation in HTLV-1 infection.
- Understanding HBZ's role provides insights into HTLV-1 pathogenesis and potential therapeutic targets.
Related Concept Videos
Abnormal Proliferation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Anaphase Promoting Complex
The JAK-STAT Signaling Pathway
The Intrinsic Apoptotic Pathway

